Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) has been assigned an average recommendation of “Buy” from the five ...

Cresco Labs (OTCMKTS:CRLBF – Get Free Report) was upgraded by stock analysts at Cormark from a “hold” rating to a “moderate ...

Still, Cresco Labs reported a free cash flow of $27 million and a net income of $0.4 million. This improved over the ...

Cresco Labs Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $175.91 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.26%.

Cresco Labs posts Q4 revenue of $175.91M, beating estimates. The company secured a Tier 3 cultivation license in Kentucky, ...

Alliance Global Partners lowered the firm’s price target on Cresco Labs (CRLBF) to C$3.25 from C$3.50 and keeps a Buy rating on the shares ...

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the ...

(“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Cresco Labs (CRLBF) to C$3.25 from C$3.50 and keeps a Buy rating ...